Profile data is unavailable for this security.
About the company
Ainos, Inc. is a diversified healthcare company, which is focused on the development of point-of-care testing (POCT), low-dose VELDONA interferon therapeutics and synthetic Ribonucleic Acid (RNA)-driven preventative medicine. The Company's products include VELDONA clinical-stage human therapeutics, VELDONA Pet cytoprotein health supplements, and telehealth-friendly POCTs powered by its AI Nose technology platform. VELDONA Pet is formulated to address a variety of health issues in dogs and cats, including skin, gum, emotion, discomfort caused by allergies, eye, and weight-related issues. Its pipeline of products, which are under development, includes VELDONA human drugs, VOC POCT-Ainos Flora, VOC platform-NISD co-development, VOC POCT-Ainos Pen, VOC POCT-CHS430 and Synthetic RNA. VELDONA human drugs are the high-priority programs include oral warts for human immunodeficiency virus seropositive patients, common cold, influenza, Sjogrens syndrome and treatment for mild COVID-19 symptoms.
- Revenue in USD (TTM)122.11k
- Net income in USD-13.77m
- Incorporated1984
- Employees46.00
- LocationAinos Inc8880 Rio San Diego Drive, Ste. 800SAN DIEGO 92108United StatesUSA
- Phone+1 (858) 869-2986
- Websitehttps://www.ainos.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Healthy Extracts Inc | 2.49m | -2.47m | 5.93m | -- | -- | 6.19 | -- | 2.38 | -0.8588 | -0.8588 | 0.8611 | 0.3231 | 0.918 | 0.4921 | 36.50 | -- | -91.32 | -53.78 | -174.02 | -146.65 | 65.90 | 45.68 | -99.48 | -87.53 | 0.1636 | -9.72 | 0.5245 | -- | 10.41 | 105.93 | -151.54 | -- | -- | -- |
Bon Natural Life Ltd | 29.52m | 4.60m | 5.95m | 96.00 | 0.856 | 0.1413 | 1.08 | 0.2017 | 4.99 | 4.99 | 32.10 | 30.23 | 0.7045 | 15.27 | 5.19 | 307,524.60 | 10.86 | 14.04 | 13.69 | 20.68 | 29.94 | 30.00 | 15.42 | 17.62 | 2.41 | 30.54 | 0.0955 | 0.00 | -1.29 | 22.32 | -26.32 | 83.09 | -6.70 | -- |
Scorpius Holdings Inc | 2.23m | -46.05m | 6.09m | 77.00 | -- | 0.1215 | -- | 2.73 | -1.78 | -2.00 | 0.0859 | 1.39 | 0.0234 | -- | 0.6762 | 28,918.57 | -50.05 | -38.42 | -61.25 | -42.06 | 29.10 | -- | -2,136.28 | -703.02 | -- | -- | 0.2305 | -- | 202.12 | 33.24 | -23.85 | -- | 218.50 | -- |
MyMD Pharmaceuticals Inc | 0.00 | -7.07m | 6.13m | 9.00 | -- | 0.2897 | -- | -- | -5.53 | -5.53 | 0.00 | 10.28 | 0.00 | -- | -- | 0.00 | -25.59 | -76.20 | -31.13 | -84.38 | -- | 7.64 | -- | -4,290.96 | -- | -- | 0.00 | -- | -- | -- | 49.15 | -- | -- | -- |
Processa Pharmaceuticals Inc | 0.00 | -11.12m | 6.14m | 13.00 | -- | 0.5542 | -- | -- | -8.72 | -8.72 | 0.00 | 3.88 | 0.00 | -- | -- | 0.00 | -154.40 | -84.35 | -175.45 | -90.03 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 59.45 | -- | -34.05 | -- |
Protagenic Therapeutics Inc | 0.00 | -5.00m | 6.14m | -- | -- | 1.67 | -- | -- | -1.15 | -1.15 | 0.00 | 0.8271 | 0.00 | -- | -- | -- | -80.91 | -74.49 | -94.48 | -92.56 | -- | -- | -- | -- | -- | -9.56 | 0.00 | -- | -- | -- | -40.64 | -- | -- | -- |
CV Sciences Inc | 16.00m | 3.10m | 6.15m | 42.00 | 1.83 | 2.10 | 1.84 | 0.384 | 0.0206 | 0.0206 | 0.104 | 0.018 | 1.46 | 1.46 | 26.74 | 381,047.60 | 28.28 | -43.42 | 247.47 | -77.75 | 44.27 | 51.81 | 19.38 | -45.68 | 0.3733 | 13.68 | 0.0805 | -- | -1.24 | -19.80 | 133.96 | -20.87 | -- | -- |
Theralink Technologies Inc | 635.46k | -13.50m | 6.15m | 16.00 | -- | -- | -- | 9.68 | -0.0027 | -0.0027 | 0.00006 | -0.0093 | 0.2525 | -- | 13.51 | 39,716.25 | -536.39 | -- | -- | -- | 73.50 | -- | -2,124.10 | -- | -- | -1.35 | -- | -- | 6.85 | -- | -138.38 | -- | -- | -- |
Ainos Inc | 122.11k | -13.77m | 6.19m | 46.00 | -- | 0.199 | -- | 50.72 | -3.32 | -3.32 | 0.0298 | 5.23 | 0.0035 | 0.9854 | 1.21 | 2,654.57 | -39.94 | -36.36 | -42.28 | -58.33 | -207.80 | 36.82 | -11,277.18 | -813.63 | 1.72 | -91.59 | 0.1961 | -- | -96.53 | 9.46 | 1.69 | -- | 66.44 | -- |
Enzon Pharmaceuticals Inc | 0.00 | 98.00k | 6.19m | 0.00 | 63.22 | 1.77 | -- | -- | 0.0013 | 0.0013 | 0.00 | 0.6197 | 0.00 | -- | -- | -- | 2.88 | -0.8654 | 2.99 | -0.8851 | -- | -- | -- | -159.43 | -- | -- | 0.00 | -- | -100.00 | -- | 106.71 | -55.86 | -- | -- |
Azitra Inc | 686.00k | -12.64m | 6.29m | 10.00 | -- | 0.9074 | -- | 9.17 | -2.99 | -2.99 | 0.0713 | 0.2408 | 0.1117 | -- | 4.88 | 68,600.00 | -183.73 | -- | -266.83 | -- | -- | -- | -1,644.87 | -- | -- | -45.86 | 0.0138 | -- | 141.55 | -- | 6.02 | -- | -- | -- |
Xenetic Biosciences Inc | 2.54m | -4.13m | 6.30m | 4.00 | -- | 0.6434 | -- | 2.48 | -2.70 | -2.70 | 1.66 | 6.36 | 0.2006 | -- | -- | 634,995.00 | -32.65 | -48.91 | -35.27 | -52.82 | -- | -- | -162.78 | -682.42 | -- | -- | 0.00 | -- | 48.80 | -- | 36.90 | -- | -- | -- |
Sentient Brands Holdings Inc | 160.00 | -379.70k | 6.37m | 2.00 | -- | -- | -- | 39,829.26 | -0.007 | -0.007 | 0.00 | -0.0308 | 0.0006 | -0.0026 | -- | 80.00 | -149.74 | -224.47 | -- | -- | 462.50 | 41.35 | -237,312.50 | -27,393.23 | 0.0005 | -0.6995 | -- | -- | -16.18 | -- | -100.19 | -- | -- | -- |
Shuttle Pharmaceuticals Holdings Inc | 0.00 | -6.59m | 6.47m | 8.00 | -- | 1.53 | -- | -- | -0.441 | -0.441 | 0.00 | 0.2524 | 0.00 | -- | -- | 0.00 | -90.28 | -- | -104.75 | -- | -- | -- | -- | -- | -- | -49.56 | 0.1527 | -- | -- | -- | -112.71 | -- | -- | -- |
Integrated BioPharma, Inc. | 50.52m | -385.00k | 6.47m | 141.00 | -- | 0.3486 | -- | 0.1281 | -0.0128 | -0.0128 | 1.68 | 0.6168 | 1.95 | 4.21 | 12.26 | 358,269.50 | -1.49 | 15.51 | -1.89 | 27.94 | 6.62 | 12.09 | -0.7621 | 6.44 | 0.8428 | -22.53 | 0.0015 | -- | -9.91 | 3.00 | -101.35 | -- | -14.03 | -- |
Holder | Shares | % Held |
---|---|---|
BlackRock Fund Advisorsas of 31 Dec 2023 | 15.33k | 0.26% |
Tower Research Capital LLCas of 31 Dec 2023 | 1.86k | 0.03% |
Wells Fargo Bank, NA (Private Banking)as of 31 Dec 2023 | 10.00 | 0.00% |
CWM LLCas of 31 Mar 2024 | 7.00 | 0.00% |
Arbor Point Advisors LLCas of 31 Dec 2023 | 3.00 | 0.00% |
Geode Capital Management LLCas of 31 Dec 2023 | 0.00 | 0.00% |
UBS Switzerland AG (Investment Management)as of 31 Dec 2023 | 0.00 | 0.00% |
SSgA Funds Management, Inc.as of 31 Dec 2023 | 0.00 | 0.00% |
Virtu Americas LLCas of 31 Dec 2023 | 0.00 | 0.00% |
UBS Securities LLCas of 31 Dec 2023 | 0.00 | 0.00% |